ORGANOVO HOLDINGS INC (ONVO) Stock News
NASDAQ:ONVO - Nasdaq - US68620A2033 - Common Stock - Currency: USD
ONVO Latest News, Press Relases and Analysis
VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market
Mentions: VIVS
VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to...
Mentions: VIVS
VivoSim to Carry Forward Organovo 3D Bioprinting
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D...
Organovo Provides Business Update
SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company...
Organovo Announces Reverse Stock Split
SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical stage biotechnology company focused on developing novel...
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology...
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
Mentions: LLY
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company...
Organovo Announces Reverse Stock Split
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises
Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises
SAN DIEGO, March 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company...